Centre for Addiction and Mental Health

Psychology & Psychiatry

Innovative neuropeptide depression treatment to be developed

The Centre for Addiction and Mental Health (CAMH) and Impel NeuroPharma have signed a licensing agreement to advance a new neuropeptide-based therapeutic approach shown to be effective in treating depression.

page 6 from 11